RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study
Launched by COLUMBIA UNIVERSITY · Dec 28, 2021
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to study how well a specific treatment, called Radiofrequency Ablation (RFA), works for patients with benign thyroid nodules, which are non-cancerous lumps in the thyroid gland. The goal is to gather information about how patients feel before and after the treatment and to see how their health outcomes improve over time. The study is currently recruiting participants who are adults aged 18 and older and do not have certain conditions like heart arrhythmias or are pregnant.
If you join this trial, you will be asked to share information about your health before and after the RFA treatment. This will help researchers understand the effectiveness of the treatment and its impact on your quality of life. As a participant, you will play an important role in helping improve care for others with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients \>/=18 years old with benign thyroid nodules
- Exclusion Criteria:
- • cardiac arrhythmia
- • pregnancy
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Jennifer H Kuo, MD MS
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials